- Forums
- ASX - By Stock
- Ann: Appendix 5B March 2023 Quarterly Cashflow
This increased capacity from China has no bearing on DYL..
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DYL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
-0.053(3.48%) |
Mkt cap ! $1.415B |
Open | High | Low | Value | Volume |
$1.51 | $1.52 | $1.45 | $4.091M | 2.785M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 19743 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 72205 | 53 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 14763 | 1.455 |
27 | 161139 | 1.450 |
15 | 142215 | 1.445 |
18 | 213076 | 1.440 |
8 | 38943 | 1.435 |
Price($) | Vol. | No. |
---|---|---|
1.460 | 48191 | 31 |
1.465 | 69551 | 13 |
1.470 | 261616 | 15 |
1.475 | 363507 | 12 |
1.480 | 25254 | 6 |
Last trade - 15.54pm 15/07/2024 (20 minute delay) ? |
Featured News
DYL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online